ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 70 filers reported holding ATHIRA PHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $59,504 | -27.4% | 20,171 | -38.4% | 0.00% | – |
| Q1 2023 | $81,925 | +88.5% | 32,770 | +139.0% | 0.00% | – |
| Q4 2022 | $43,464 | -48.9% | 13,711 | -52.1% | 0.00% | – |
| Q3 2022 | $85,000 | +77.1% | 28,623 | +81.8% | 0.00% | – |
| Q2 2022 | $48,000 | -80.2% | 15,746 | -12.3% | 0.00% | – |
| Q1 2022 | $242,000 | -6.9% | 17,962 | -10.1% | 0.00% | – |
| Q4 2021 | $260,000 | -28.0% | 19,987 | -48.1% | 0.00% | – |
| Q3 2021 | $361,000 | +53.0% | 38,480 | +67.1% | 0.00% | – |
| Q2 2021 | $236,000 | +50.3% | 23,031 | +169.0% | 0.00% | – |
| Q1 2021 | $157,000 | -49.2% | 8,561 | -5.0% | 0.00% | – |
| Q4 2020 | $309,000 | – | 9,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,630,744 | $21,249,000 | 2.19% |
| VR Adviser, LLC | 1,000,000 | $13,030,000 | 1.78% |
| ACUTA CAPITAL PARTNERS, LLC | 310,030 | $4,040,000 | 1.70% |
| Ikarian Capital, LLC | 860,000 | $11,207,000 | 1.67% |
| Bristlecone Advisors, LLC | 761,563 | $9,923,000 | 1.19% |
| Perceptive Advisors | 6,851,832 | $89,280,000 | 0.69% |
| DAFNA Capital Management LLC | 160,983 | $2,098,000 | 0.53% |
| PATHSTONE FAMILY OFFICE, LLC | 1,442,247 | $18,792,000 | 0.47% |
| Potomac Capital Management, Inc. | 40,000 | $521,000 | 0.46% |
| RTW INVESTMENTS, LP | 1,906,557 | $24,842,000 | 0.36% |